OpenAlex
PricingAboutJobs
Log inGet started
Work

Combination of cytotoxic-differentiation therapy with 5-fluorouracil and phenylbutyrate in patients with advanced colorectal cancer.

PubMed

Year: 2007
Type: article
Study design: Clinical Trial
Source: PubMed
Authors: Max W Sung, Samuel Waxman
Institutions: Mount Sinai Hospital, Icahn School of Medicine at Mount Sinai
Language: English

Topic: Histone Deacetylase Inhibitors Research
Subfield: Molecular Biology
Field: Biochemistry, Genetics and Molecular Biology
Domain: Life Sciences
Keywords: 5-fluorouracil, 4-phenylbutyric acid, histone deacetylase inhibitors, advanced colorectal cancer, metastatic colorectal cancer, combination chemotherapy, continuous intravenous infusion, drug toxicity, dose escalation
SDG: Good health and well-being

Open Access status: closed

Funder: National Cancer Institute
Award: ARSENIC TRIOXIDE TREATMENT OF LYMPHOPROLIFERATIVE DISORD
OpenAlex ID: W2182042977
FWCI: 0.853
Cites: 20
Cited by: 42
Related to: 10
OpenAlex
Nonprofit
Open DataOpen Data
Open Source
Product
Search
Compare
Pricing
Repositories
Unpaywall
Unsub
Developers
API docs
Data snapshot
Status
Source code
Organization
About
Team
Testimonials
Brand
Jobs
Community
Help center
Contact
Events
Blog
Mailing list
Supporters
Legal
Privacy
Accessibility
Terms